Cytogenetic Abnormality in Patients With multiple Myeloma Analyzed by Fluorescent in Situ Hybridization

OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s95818
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Cytogenetic and Interphase Fluorescence in Situ Hybridization Studies in Patients With Multiple Myeloma

Molecular Cytogenetics
BiochemistryMolecular MedicineGeneticsMolecular Biology
2014English

Prognostic Value of Chromosome 1q21 Gain by Fluorescent in Situ Hybridization and Increase CKS1B Expression in Myeloma

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2006English

Clinical Implications of Cytogenetic Heterogeneity in Multiple Myeloma Patients With TP53 Deletion

Modern Pathology
Forensic MedicinePathology
2017English

Cytogenetic Study of 48 Patients With Multiple Myeloma and Related Disorders

Journal of clinical and experimental hematopathology : JCEH
Medicine
2003English

Cytogenetic Abnormalities in Multiple Myeloma Patients at a Tertiary Healthcare Center in India

Asian Pacific Journal of Cancer Prevention
2019English

Occurrence of Listeria Monocytogenes in Silages Assessed by Fluorescent in Situ Hybridization

Arquivo Brasileiro de Medicina Veterinaria e Zootecnia
Veterinary
2008English

A Continuum of Transcriptional Identities Visualized by Combinatorial Fluorescent in Situ Hybridization

Development (Cambridge)
Developmental BiologyMolecular Biology
2012English

Differences in the Distribution of Cytogenetic Subtypes Between Multiple Myeloma Patients With and Without a Family History of Monoclonal Gammopathy and Multiple Myeloma

European Journal of Haematology
MedicineHematology
2013English

Results of Cytogenetic and Molecular Cytogenetic Studies in Relapce/Refractory of Multiple Myeloma

Innovative Biosystems and Bioengineering
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy